Login
PetIQ, Inc. logo

PetIQ, Inc.

Compare classes
petiq.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Aug 8, 2024. Its latest SEC filing is a SC 13G/A from Nov 14, 2024.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Manufactures and distributes pet medications and health and wellness products through retail and e-commerce channels, and provides veterinary services directly to pet owners.

How Did They Make Money?

Retailers and e-commerce customers pay for products when they are shipped or delivered. Pet owners generally pay when veterinary services are provided.

FY2023 revenue by product or service revenue
SegmentShareRevenue
Product
88%
FY2020: 93%
Service
12%
FY2020: 7.0%

Who Were Their Customers?

Retail chains, pet specialty stores, e-commerce businesses and pharmacies buy products, while consumers purchase veterinary services directly at clinics and wellness centers.

Customers above 10% of revenue, FY2023
of revenue from two customers (28%, 15%)
FY2022: 35% from two customers

Did Revenues Turn Into Profits?

Yes. It kept less than a cent of every revenue dollar as net income in FY2023 and turned 5 cents into free cash flow.

Operating income, FY2023
3% of revenue
▲ Turned profitable vs FY2022 (−$20.2M, −2%)
Net income, FY2023
0% of revenue
▲ Turned profitable vs FY2022 (−$48.2M, −5%)
Free cash flow, FY2023
5% of revenue
▲ +46% vs FY2022 ($36.1M, 4%)

How Were They Changing?

Since the FY2023 annual report
Latest quarter: Q2 FY2024, the three months to Jun 30, 2024
Revenue
▲ +5%
vs $314.5M in Q2 FY2023
Net income
▲ +62%
vs $9.5M in Q2 FY2023
Products share of revenue vs 88.4% in Q2 FY2023
  • Oct 25, 2024 Bansk Group completed its acquisition of PetIQ, which was delisted PetIQ became privately held and continues to operate independently under its executive team.

Grew. Revenue grew 55% in 4 years, from $709.4M in FY2019 to $1.1B in FY2023, about 12% a year.

Broader product range The latest report describes health and wellness products alongside pet medications, including treats and other wellness items; the older report focused on pet medications and veterinary products and services.

Revenue over time
Product Service
$2B$1B$0

Who Did They Compete With?

Competes with Elanco, Hartz, Mars, Manna Pro, Nestlé, Spectrum Holdings, Promika, Tevra Brands, The J.M. Smucker, Banfield Pet Hospitals, VCA Animal Hospitals, and Petco

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support